menu
    • menu

    Company profile for LogicBio Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases. We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology, GeneRide, is well-suited to this goal because – unlike traditional gene therapy – it harnesses the cell’s natural DNA repa...
    At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases. We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology, GeneRide, is well-suited to this goal because – unlike traditional gene therapy – it harnesses the cell’s natural DNA repair process to integrate a corrective gene directly into the patient’s chromosomes. This approach is designed to provide a durable therapeutic benefit from a single treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LogicBio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    99 Erie St. Cambridge, MA 02139
    Telephone
    Telephone
    617-245-0399
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.logicbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/logicbio-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/logicbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alexion, AZ Rare Disease, Completes Acquisition of LogicBio Therapeutics
    Alexion, AZ Rare Disease, Completes Acquisition of LogicBio Therapeutics

    16 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115006592/en/Alexion-AstraZeneca-Rare-Disease-Completes-Acquisition-of-LogicBio%C2%AE-Therapeutics

    BUSINESSWIRE
    16 Nov 2022
    Share Share
    Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio
    Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio

    16 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115006592/en

    BUSINESSWIRE
    16 Nov 2022
    Share Share
    LogicBio Therapeutics Reports Third Quarter 2022 Financial Results
    LogicBio Therapeutics Reports Third Quarter 2022 Financial Results

    14 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/logicbio-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-updates-301676349.html

    PRNEWSWIRE
    14 Nov 2022
    Share Share
    Alexion, AstraZeneca Rare Disease to Acquire LogicBio
    Alexion, AstraZeneca Rare Disease to Acquire LogicBio

    04 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/alexion-astrazeneca-rare-disease-to-acquire-logicbio-therapeutics-to-accelerate-growth-in-genomic-medicine-301638676.html

    PRNEWSWIRE
    04 Oct 2022
    Share Share
    LogicBio Therapeutics Announces Pre-Clinical Results for mLB-001 Published
    LogicBio Therapeutics Announces Pre-Clinical Results for mLB-001 Published

    21 Sep 2022

    // APNEWS

    https://apnews.com/article/mlb-science-health-sports-genetics-56e237a81e32df89e5ab8fd77b7ff01d

    APNEWS
    21 Sep 2022
    Share Share
    LogicBio Announces Results for mLB-001 Published in Journal PLOS ONE
    LogicBio Announces Results for mLB-001 Published in Journal PLOS ONE

    21 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/logicbio-therapeutics-announces-pre-clinical-results-for-mlb-001-published-in-peer-reviewed-journal-plos-one-301629249.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search